Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Barreiro

Showing results (191-200 of 522) with videos related to

Pageof 53
Sort By:
The European Respiratory Journal|July 29, 2003
Therapeutic potential of a new phosphodiesterase inhibitor in acute lung injuryP R M Rocco, D P Momesso, R C Figueira, et al.
Molecules (Basel, Switzerland)|August 27, 2021
Design and Synthesis In Silico Drug-like Prediction and Pharmacological Evaluation of Cyclopolymethylenic Homologous of LASSBio-1514Lidia Moreira Lima, Tiago Fernandes da Silva, Carlos Eduardo da Silva Monteiro, et al.
Bioorganic & Medicinal Chemistry|January 13, 2009
Novel 6-methanesulfonamide-3,4-methylenedioxyphenyl-N-acylhydrazones: orally effective anti-inflammatory drug candidatesJorge L M Tributino, Carolina D Duarte, Rodrigo S Corrêa, et al.
Molecules (Basel, Switzerland)|November 30, 2012
Design, synthesis, antinociceptive and anti-inflammatory activities of novel piroxicam analoguesAmanda Silva de Miranda, Walfrido Bispo Júnior, Yolanda Karla Cupertino da Silva, et al.
Frontiers in Physiology|October 21, 2015
Therapeutic effects of LASSBio-596 in an elastase-induced mouse model of emphysemaGisele A Padilha, Isabela Henriques, Miquéias Lopes-Pacheco, et al.
Ophthalmic Research|July 11, 2012
Potential inhibitory effect of LASSBio-596, a new thalidomide hybrid, on inflammatory corneal angiogenesis in rabbitsJoao Crispim M L Ribeiro, Francisco Vagnaldo Fechine, Mariana Zaira M L Ribeiro, et al.
Bioorganic & Medicinal Chemistry|August 25, 2009
Synthesis and analgesic profile of conformationally constrained N-acylhydrazone analogues: discovery of novel N-arylideneamino quinazolin-4(3H)-one compounds derived from natural safroleRodolfo C Maia, Leandro L Silva, Eduardo F Mazzeu, et al.
European Journal of Medicinal Chemistry|June 25, 2013
Synthesis and pharmacological evaluation of new N-phenylpiperazine derivatives designed as homologues of the antipsychotic lead compound LASSBio-579Thais E T Pompeu, Fernando R S Alves, Carolina D M Figueiredo, et al.
Bioorganic & Medicinal Chemistry|October 15, 2003
Design, synthesis and pharmacological profile of novel dopamine D2 receptor ligandsRicardo Menegatti, Anna C Cunha, Vítor F Ferreira, et al.
European Journal of Pharmacology|March 29, 2005
Evaluating the prophylactic potential of the phtalimide derivative LASSBio 552 on allergen-evoked inflammation in ratsJosiane S Neves, Lídia M Lima, Carlos A M Fraga, et al.
Pageof 53

Showing results (191-200 of 522) with videos related to

Sort By:
Pageof 53
The European Respiratory Journal|July 29, 2003
Therapeutic potential of a new phosphodiesterase inhibitor in acute lung injuryP R M Rocco, D P Momesso, R C Figueira, et al.
Molecules (Basel, Switzerland)|August 27, 2021
Design and Synthesis In Silico Drug-like Prediction and Pharmacological Evaluation of Cyclopolymethylenic Homologous of LASSBio-1514Lidia Moreira Lima, Tiago Fernandes da Silva, Carlos Eduardo da Silva Monteiro, et al.
Bioorganic & Medicinal Chemistry|January 13, 2009
Novel 6-methanesulfonamide-3,4-methylenedioxyphenyl-N-acylhydrazones: orally effective anti-inflammatory drug candidatesJorge L M Tributino, Carolina D Duarte, Rodrigo S Corrêa, et al.
Molecules (Basel, Switzerland)|November 30, 2012
Design, synthesis, antinociceptive and anti-inflammatory activities of novel piroxicam analoguesAmanda Silva de Miranda, Walfrido Bispo Júnior, Yolanda Karla Cupertino da Silva, et al.
Frontiers in Physiology|October 21, 2015
Therapeutic effects of LASSBio-596 in an elastase-induced mouse model of emphysemaGisele A Padilha, Isabela Henriques, Miquéias Lopes-Pacheco, et al.
Ophthalmic Research|July 11, 2012
Potential inhibitory effect of LASSBio-596, a new thalidomide hybrid, on inflammatory corneal angiogenesis in rabbitsJoao Crispim M L Ribeiro, Francisco Vagnaldo Fechine, Mariana Zaira M L Ribeiro, et al.
Bioorganic & Medicinal Chemistry|August 25, 2009
Synthesis and analgesic profile of conformationally constrained N-acylhydrazone analogues: discovery of novel N-arylideneamino quinazolin-4(3H)-one compounds derived from natural safroleRodolfo C Maia, Leandro L Silva, Eduardo F Mazzeu, et al.
European Journal of Medicinal Chemistry|June 25, 2013
Synthesis and pharmacological evaluation of new N-phenylpiperazine derivatives designed as homologues of the antipsychotic lead compound LASSBio-579Thais E T Pompeu, Fernando R S Alves, Carolina D M Figueiredo, et al.
Bioorganic & Medicinal Chemistry|October 15, 2003
Design, synthesis and pharmacological profile of novel dopamine D2 receptor ligandsRicardo Menegatti, Anna C Cunha, Vítor F Ferreira, et al.
European Journal of Pharmacology|March 29, 2005
Evaluating the prophylactic potential of the phtalimide derivative LASSBio 552 on allergen-evoked inflammation in ratsJosiane S Neves, Lídia M Lima, Carlos A M Fraga, et al.
Pageof 53